In vivo nanotoxicological profile of graphene oxide

Abstract

Graphene oxide, a widely studied nano materials, exhibits numerous beneficial effects in medical devices. The graphene sample Graphene oxide (GO):Single-layer graphene oxide, purity 99%, thickness 0.7-1.2 nm (AFM); ∼300-800nm X&Y dimensions is the standard size <450 nm & 1-20 μm lateral dimensions from Cheap Tubes Inc., Bratleboro, USA was selected for this study. Characterization of GO and stability were previously studied. All the assays were carried out at a concentration of 1 mg/mL (stock suspension by ultrasonication)(stable 10 days). In this study the first parameter evaluated was in animal toxicity in acute and chronic responses. The second one was to observe the morphology and histological changes on major organs, like signs of inflammatory areas. A total of 25 rats (Fischer 344) were divide in 5 groups (n = 5 animals): negative control group (NCT); Positive cancer control group (PCCT); GO group-1 (GO 1); GO group-2 (GO 2) and GO group-3 (GO 3), with different concentrations of graphene oxide. All the groups were treated by via intra peritoneal (i.p) administration. Biochemical and histopathology results of acute toxicity showed no alterations. In the chronic toxicity was found deposit sections and morphology alterations in different tissues (inflammations). Genotoxicity was dose dependent of GO. This study gave us the limit concentrations of GO free for any biological study.